Avanos Medical, Inc.
AVNS
$24.96
-$0.01-0.02%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 715.90M | 701.20M | 699.90M | 692.50M | 689.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 715.90M | 701.20M | 699.90M | 692.50M | 689.20M |
| Cost of Revenue | 357.60M | 347.30M | 334.00M | 319.70M | 312.90M |
| Gross Profit | 358.30M | 353.90M | 365.90M | 372.80M | 376.30M |
| SG&A Expenses | 326.90M | 325.80M | 329.90M | 327.00M | 324.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.60M | 1.00M | 4.50M | 1.60M | 3.40M |
| Total Operating Expenses | 699.50M | 685.70M | 677.50M | 658.60M | 651.50M |
| Operating Income | 16.40M | 15.50M | 22.40M | 33.90M | 37.70M |
| Income Before Tax | -68.30M | -66.20M | -487.90M | -477.20M | -395.10M |
| Income Tax Expenses | 6.10M | 6.70M | -19.30M | -15.90M | -14.90M |
| Earnings from Continuing Operations | -74.40 | -72.90 | -468.60 | -461.30 | -380.20 |
| Earnings from Discontinued Operations | -- | -- | -300.00K | -1.90M | -4.40M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.40M | -72.90M | -468.90M | -463.20M | -384.60M |
| EBIT | 16.40M | 15.50M | 22.40M | 33.90M | 37.70M |
| EBITDA | 55.90M | 54.40M | 62.50M | 76.30M | 81.40M |
| EPS Basic | -1.61 | -1.57 | -10.18 | -10.06 | -8.36 |
| Normalized Basic EPS | 0.15 | 0.15 | 0.23 | 0.37 | 0.44 |
| EPS Diluted | -1.61 | -1.58 | -10.19 | -10.07 | -8.38 |
| Normalized Diluted EPS | 0.15 | 0.15 | 0.23 | 0.37 | 0.44 |
| Average Basic Shares Outstanding | 185.60M | 185.20M | 184.80M | 184.40M | 184.00M |
| Average Diluted Shares Outstanding | 186.60M | 185.90M | 185.50M | 185.70M | 185.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |